AI-generated summary
The authors describe two case reports of women with refractory dermal melasma treated with 10 weekly sessions of the MedLite C6 Q-switched Nd:YAG laser combined with topical alpha arbutin and sunscreen. They report over 80% reduction in hyperpigmentation in both cases, with no recurrence at follow-up. As only two patients were treated, these findings cannot be generalized.
- Participants
- 2
- Who or what was studied
- Two Asian women aged 45 and 50 with refractory dermal melasma (Fitzpatrick skin types III-V)
- Limits stated in the abstract
- The report covers only two cases, with no control group and follow-up of 6 months to 1 year.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tandfonline.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Melanin. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.